We confirmed that ME2 promotes SREBP-1 maturation and nuclear localization and increases ACSS2 expression, indicating that ME2 upregulates de novo lipogenesis, probably via AMPK–SREBP-1–ACSS2, in glioma cells. This evidence concerns the gene SREBF1 and central nervous system cancer.